Version 3.8 of Qlucore Omics Explorer enables faster and improved data visualizations. Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools, announces Qlucore Omics Explorer (QOE) version 3.8, with new features that will improve ease of use and enhance performance. Qlucore Omics Explorer is a next-generation bioinformatics software for research in life science, […]
Protein Metrics is market-leading software leveraged by more than 450 scientific enterprises for the large-scale study of proteins San Diego, CA, 21 December 2021: Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire Protein Metrics, Inc., a leading provider of biopharmaceutical protein characterization and proteomics analysis software. […]
Company poised to transform personalized drug development and clinical healthcare in 2022, following series of key pharma partnerships leveraging its leading genomics platform and global real-world data access network Latest partnership, with the Colorado Center for Personalised Medicine, could prove pivotal for identifying gene-drugs conflicts in clinical practice BC Platforms (BCP), a global leader in […]
Remix Therapeutics is a Boston-based biotechnology company developing novel small molecule therapies for reprogramming RNA processing and treating disease in entirely new ways. As protein targeting therapies reach the limits of what can be easily druggable, reprogramming RNA processing offers an exciting new therapeutic opportunity. While protein dysfunction is often the direct cause of disease, the […]
Genedata Biologics integrates, automates, and streamlines Ligand Pharmaceuticals’ OmniAb in vivo antibody discovery platform Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Ligand Pharmaceuticals (NASDAQ: LGND) has chosen Genedata Biologics® as the global biologics R&D workflow and data management platform for their OmniAb antibody discovery platform. […]
Bellinzona, Switzerland – BigOmics Analytics SA (“BigOmics”), a Swiss biodata analytics startup, announced today that it raised a total of $1.85 million in financing. This funding will allow the company to expand its team and to commercialize its governed self-service analytics (GSSA) platforms to empower life scientists. BigOmics raised $1.42 million on the first closing of […]
Dr. David Ledbetter Named Chief Clinical and Research Officer of UPN BOSTON – Seven Bridges Genomics, the industry-leading bioinformatics ecosystem provider, today announced the formation of a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies with a focus on advancing precision medicine and improving […]
Dr. David Ledbetter Named Chief Clinical and Research Officer of UPN BOSTON – Seven Bridges Genomics, the industry-leading bioinformatics ecosystem provider, today announced the formation of a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies with a focus on advancing precision medicine and improving […]
Genedata Screener to be adopted worldwide at AstraZeneca for all in-vitro testing, focusing on biotherapeutics discovery as well as specialized modalities of PROTACs and CRISPR. Basel, Switzerland — Genedata, a leading provider of enterprise software solutions for biopharma R&D, today announced an expanded licensing agreement with AstraZeneca for Genedata Screener® which will support the company’s […]
HELSINKI, Finland — Euformatics, Finnish bioinformatics software company, has today announced that its genomic variant interpretation and reporting tool, omnomicsNGS, has been granted the CE-IVD mark under the In-Vitro Diagnostics Directive (98/79/EC). The software, previously a CE-marked medical device class I under preceding EU legislation, is now making strong progress on its journey to being […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
